Ara mostrant els elements 1-2 de 2
Rabionet Diaz, Marc (Data de defensa: 2021-11-08)
Triple negative breast cancer (TNBC) accounts for 15-20% of the breast cancers and displays an aggressive profile, poor prognosis, high relapse risk and does not have a targeted therapy. In the last years, breast cancer ...
Polonio Alcalá, Emma (Data de defensa: 2023-05-17)
Although there are therapies for triple negative breast cancer (TNBC) and epidermal growth factor-mutated non-small cell lung cancer (EGFRm NSCLC), these two subtypes of cancer are very aggressive, and most patients develop ...